As always - I hope this works. If it doesn't, it's on the Telus home page.
The New England Journal of Medicine (NEJM) has hailed BC Cancer Agency-led research as the Hodgkin’s lymphoma “breakthrough we have been looking for” because it can predict which patients can be cured and which ones will likely relapse.
Read full story>
The New England Journal of Medicine (NEJM) has hailed BC Cancer Agency-led research as the Hodgkin’s lymphoma “breakthrough we have been looking for” because it can predict which patients can be cured and which ones will likely relapse.
Read full story>
